TESAMORELIN
Synthetic GHRH analogue for GH-releasing research. 40+ peer-reviewed preclinical studies. 3-lab independent COA on every batch.
What is Tesamorelin?
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH). It consists of a modified 44-amino-acid GHRH sequence designed to stimulate growth hormone release from the anterior pituitary. A pharmaceutical formulation of tesamorelin holds FDA approval for one specific clinical indication. That approval applies to the pharmaceutical product only — it does not extend to research-grade material, which is supplied here for preclinical study of the GH axis.
With 40+ preclinical publications, Tesamorelin has been studied extensively in models of visceral adiposity, GH-axis signaling, body-composition endpoints, and lipodystrophy-related metabolic signaling.
Published preclinical research areas
Visceral adiposity models
Studied in preclinical models examining visceral adipose endpoints via GH-mediated lipolysis pathways. Research examines differential change between trunk and subcutaneous adipose compartments in animal models.
GH axis restoration
Preclinical studies examine pulsatile GH-release patterns following GHRH receptor activation through GHRH receptor activation. Research has explored age-related GH decline models and feedback loop restoration.
Body composition signaling
Research examines changes in lean mass to fat mass ratio, IGF-1 pathway activation, and metabolic rate modulation in preclinical body-composition models.
Lipodystrophy research
Extensive preclinical and translational research on Tesamorelin's role in lipodystrophy-related fat redistribution models, including HIV-associated lipodystrophy signaling pathways.
Available formulations at SMART MD
SMART MD quality standard for Tesamorelin
- HPLC purity analysis — identity and purity confirmed via high-performance liquid chromatography.
- Mass spectrometry — molecular weight confirmation. Verifies correct peptide sequence.
- LAL endotoxin assay — <5 EU/mg. Bacterial endotoxin safety verification.
- 3 independent U.S. laboratories — rotating panel. No single lab relationship can compromise verification integrity.
- Lot-specific COA — publicly verifiable at smartmdpeptides.com/verify before you reach out.
Questions about this compound?
A SMART rep can walk you through the formulations we document, the lot-specific COA for any batch, purity and endotoxin data, and storage and handling requirements for your protocol. Leave your name, email, phone, and what you're researching — a rep follows up within one business day. Research use only: we do not provide dosing, administration, or human-use guidance of any kind, and nothing we send is medical advice.
Tesamorelin FAQ
What Tesamorelin formulations does SMART MD document?+
Research-grade Tesamorelin with 3-lab COA verification is available at SMART MD Peptides in 5mg and 10mg formulations. Every batch is publicly verifiable at smartmdpeptides.com/verify.
What is the purity of SMART MD's Tesamorelin?+
Every Tesamorelin batch is third-party tested with a published COA. Each batch is independently verified by 3 U.S. laboratories — HPLC for purity, mass spectrometry for molecular weight, and LAL endotoxin assay for safety.
What makes Tesamorelin unique among GHRH peptides?+
Tesamorelin is a GHRH analogue with an FDA-approved pharmaceutical formulation for a specific indication. The research-grade version available at SMART MD is for preclinical study of the GH axis, visceral adiposity, and body composition models.
Is Tesamorelin legal for research?+
Tesamorelin is legal to acquire for research purposes. It is classified as a research-use-only compound — not intended for human consumption in this form. Qualified researchers and research institutions may request documentation for preclinical laboratory research.
How should Tesamorelin be stored?+
Lyophilized (unreconstituted) Tesamorelin should be stored at -20°C, protected from light. Once reconstituted, store at 2-8°C and use within the timeframe specified on your lot-specific documentation.